SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-285889
Filing Date
2019-11-06
Accepted
2019-11-06 16:08:03
Documents
14
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d826856d8k.htm   iXBRL 8-K 27092
2 EX-99.1 d826856dex991.htm EX-99.1 93983
6 GRAPHIC g826856g1106091147930.jpg GRAPHIC 3173
  Complete submission text file 0001193125-19-285889.txt   261663

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20191106.xsd EX-101.SCH 3097
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20191106_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20191106_pre.xml EX-101.PRE 11426
9 EXTRACTED XBRL INSTANCE DOCUMENT d826856d8k_htm.xml XML 3369
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 191196341
SIC: 2834 Pharmaceutical Preparations